» Articles » PMID: 35980984

FGFRL1 and FGF Genes Are Associated with Height, Hypertension, and Osteoporosis

Overview
Journal PLoS One
Date 2022 Aug 18
PMID 35980984
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension and osteoporosis are two major disorders, which interact with each other. Specific genetic signals involving the fibroblast growth factor receptor-like 1 (FGFRL1) gene are related to high blood pressure and bone growth in giraffes. FGFRL1 is associated with cardiovascular system and bone formation. We performed an association study to investigate the role of FGFRL1 in hypertension, osteoporosis, and height determination in humans. In addition, we identified three kinds of phenotypes in fibroblast growth factor (FGF) genes and examined their association with the FGFRL1 gene. We identified 42 SNPs in the FGFRL1 gene associated with each trait. We then analyzed the potential functional annotation of each SNP. The FGFRL1 gene was found to be associated with height, hypertension, and osteoporosis, consistent with the results of a previous study. In addition, the FGF2, FGF4, FGF10, FGF18, and FGF22 genes were found to interact with the FGFRL1 gene. Our study suggests that both FGFRL1 and FGFRL1-related genes may determine the height and the prevalence of osteoporosis and hypertension in the Korean population.

Citing Articles

Effectiveness of Spironolactone in Reducing Osteoporosis and Future Fracture Risk in Middle-Aged and Elderly Hypertensive Patients.

Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H Drug Des Devel Ther. 2024; 18:2215-2225.

PMID: 38882049 PMC: 11180452. DOI: 10.2147/DDDT.S466904.


Association between hypertension and osteoporosis: a population-based cross-sectional study.

Huang Y, Ye J BMC Musculoskelet Disord. 2024; 25(1):434.

PMID: 38831414 PMC: 11149290. DOI: 10.1186/s12891-024-07553-4.


Roles of fibroblast growth factors in the treatment of diabetes.

Zhang C, Yang M World J Diabetes. 2024; 15(3):392-402.

PMID: 38591079 PMC: 10999039. DOI: 10.4239/wjd.v15.i3.392.


Genomics of Wolfram Syndrome 1 (WFS1).

Koks S Biomolecules. 2023; 13(9).

PMID: 37759745 PMC: 10527379. DOI: 10.3390/biom13091346.

References
1.
Beenken A, Mohammadi M . The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009; 8(3):235-53. PMC: 3684054. DOI: 10.1038/nrd2792. View

2.
Liao S, Bodmer J, Pietras D, Azhar M, Doetschman T, Schultz J . Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Dev Dyn. 2008; 238(2):249-64. PMC: 3115589. DOI: 10.1002/dvdy.21677. View

3.
Kichaev G, Bhatia G, Loh P, Gazal S, Burch K, Freund M . Leveraging Polygenic Functional Enrichment to Improve GWAS Power. Am J Hum Genet. 2019; 104(1):65-75. PMC: 6323418. DOI: 10.1016/j.ajhg.2018.11.008. View

4.
Catela C, Bilbao-Cortes D, Slonimsky E, Kratsios P, Rosenthal N, Te Welscher P . Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice. Dis Model Mech. 2009; 2(5-6):283-94. PMC: 2675798. DOI: 10.1242/dmm.002287. View

5.
Ornitz D, Marie P . Fibroblast growth factors in skeletal development. Curr Top Dev Biol. 2019; 133:195-234. DOI: 10.1016/bs.ctdb.2018.11.020. View